The Patent Finder

Vyrexip Holdings, Inc.

Also on record
Records under this name other than patents Vyrexip Holdings, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Vyrexip Holdings, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,541,613Isoflavone derivatives
Term ended
Term ended Dec 15, 2020 · USPTO record
Term endedTerm ended Dec 15, 2020USPTO record
US 6,362,234Water-soluble prodrugs of propofol for treatment of migrane
Formerly held
Term ended
Term ended Aug 15, 2020 · USPTO record
Term endedTerm ended Aug 15, 2020USPTO record
US 6,254,853Water soluble pro-drugs of propofol
Formerly held
Term ended
Term ended May 8, 2018 · USPTO record
Term endedTerm ended May 8, 2018USPTO record
US 4,985,465Method for inhibiting viral and retroviral infections
Term ended
Term ended no later than Jan 15, 2011 · Low confidence
Term endedTerm ended no later than Jan 15, 2011Low confidence
US 5,114,957Tocopherol-based antiviral agents and method of using same
Term ended
Term ended no later than May 19, 2012 · Low confidence
Term endedTerm ended no later than May 19, 2012Low confidence
US 5,981,603Antiviral agents
Term ended
Term ended no later than Nov 9, 2019 · Low confidence
Term endedTerm ended no later than Nov 9, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited